Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Carcinoma, Anaplastic × Blood Specimen Collection × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Breast Neoplasms 103 Neoplasms 97 Colorectal Neoplasms 52 Lung Neoplasms 51 Prostatic Neoplasms 40 Carcinoma, Non-Small-Cell Lung 40 Melanoma 33 Pancreatic Neoplasms 31 Ovarian Neoplasms 25 Neoplastic Cells, Circulating 25 Head and Neck Neoplasms 24 Colonic Neoplasms 20 Multiple Myeloma 19 Uterine Cervical Neoplasms 18 Neoplasm Metastasis 17 Leukemia, Myeloid, Acute 17 Carcinoma, Hepatocellular 17 Sarcoma 16 Glioma 16 Hematologic Neoplasms 14 Esophageal Neoplasms 14 Lymphoma 13 Glioblastoma 13 Squamous Cell Carcinoma of Head and Neck 12 Leukemia 12 Endometrial Neoplasms 12 Myelodysplastic Syndromes 11 Kidney Neoplasms 11 Carcinoma, Renal Cell 10 Brain Neoplasms 10

Interventions

trametinib 9 dabrafenib 9 Paclitaxel 9 pembrolizumab 4 fosbretabulin 4 lenvatinib 3 Sorafenib 3 Radiotherapy, Intensity-Modulated 3 efatutazone 2 combretastatin 2 cobimetinib 2 atezolizumab 2 aldesleukin 2 Vemurafenib 2 Trastuzumab 2 Radiotherapy 2 Gefitinib 2 Filgrastim 2 Everolimus 2 Doxorubicin 2 Docetaxel 2 Cisplatin 2 Carboplatin 2 zimberelimab 1 vandetanib 1 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tremelimumab 1 tislelizumab 1 tipifarnib 1 surufatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01774279 2021-01-05

iNATT

Velindre NHS Trust

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡